Selenoprotein P, a liver-derived secretory protein, regulates pressure overload-induced cardiac remodeling
Project/Area Number |
15K09135
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Cardiovascular medicine
|
Research Institution | Kanazawa University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 心臓リモデリング / 心不全 / 心肝連関 / ヘパトカイン / 心肥大 / マイクロアレイ / 肝臓 |
Outline of Final Research Achievements |
Selenoprotein P (SeP) is a liver-derived secretory protein that impairs insulin signal transduction and induces insulin resistance and hyperglycemia. Although clinical studies suggest the insulin resistance is an independent risk factor of heart failure, the role of SeP in pathogenesis of chronic heart failure is not well understood. We investigated the role of SeP in the regulation of cardiac remodeling in response to pressure overload. Transverse aortic constriction (TAC) was subjected to SeP knockout (KO) and wild-type (WT) mice for 2 weeks. The mortality rate following TAC was significantly decreased in SeP KO mice compared to WT mice. LV weight/body weight (BW) and Lung weight/BW were significantly smaller in SeP KO mice than in WT mice. Furthermore, mRNA expression of collagen 1a1 significantly less in SeP KO compared to WT. These results suggest that the absence of endogenous SeP attenuated cardiac hypertrophy, dysfunction and fibrosis in response to pressure overload in mice
|
Report
(4 results)
Research Products
(11 results)
-
[Journal Article] Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.2018
Author(s)
Chikata A, Kato T, Usuda K, Fujita S, Maruyama M, Nagata Y, Sakagami S, Kanamori N, Yaegashi T, Saeki T, Kusayama T, Usui S, Furusho H, Kaneko S, Takamura M.
-
Journal Title
Int J Mol Sci.
Volume: 19
Issue: 3
Pages: 878-878
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.2017
Author(s)
Ohkura SI, Usui S, Takashima SI, Takuwa N, Yoshioka K, Okamoto Y, Inagaki Y, Sugimoto N, Kitano T, Takamura M, Wada T, Kaneko S, Takuwa Y.
-
Journal Title
PLoS One.
Volume: 12
Issue: 8
Pages: e0182329-e0182329
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Adipose-derived regenerative cells exert beneficial effects on systemic responses following myocardial ischemia/reperfusion.2016
Author(s)
Takamura M, Usui S, Inoue O, Ootsuji H, Takashima SI, Nomura A, Kato T, Murai H, Furusho H, Sakai Y, Kaneko S.
-
Journal Title
Cardiol J
Volume: 23
Issue: 6
Pages: 685-693
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-